Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and highly effective treatment of cancer. ADCs are antibody-drug conjugates that combine the specificity of antibodies with the efficacy of toxins to fight cancer. Selected antibodies are loaded with cytotoxic compounds, the so-called payloads, that are transported into diseased cells. Inside the cells, the toxins then unleash their effect and kill the diseased cells.
Heidelberg Pharma uses several compounds and has built up an ADC toolbox that overcomes tumor resistance via numerous pathways and addresses different types of cancer using various antibodies. The goal is to develop targeted and highly effective ADCs for the treatment of a variety of malignant hematologic and solid tumors.
The company is listed on the Frankfurt Stock Exchange (FSE: HPHA). More information is available at www.heidelberg-pharma.com.
Company Details
- Employees
- 47
- Address
- Gregor-Mendel-Straße 22, Ladenburg,baden-Württemberg 68526,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.heidelberg-pharma.com
- Keywords
- Onkologie, ADC, ATAC, Amanitin.
- HQ
- Ladenburg, Baden-Württemberg
Heidelberg Pharma Ag Questions
Heidelberg Pharma Ag's website is http://www.heidelberg-pharma.com
Heidelberg Pharma Ag's LinkedIn profile is https://de.linkedin.com/company/heidelberg-pharma-ag
Heidelberg Pharma Ag has
47 employees.
View email and phone details for 47
employees at Heidelberg Pharma Ag.
Heidelberg Pharma Ag's industry is
Biotechnology Research
Heidelberg Pharma Ag's top competitors are
Biomed X Institute,
Biolabs Heidelberg,
Immatics,
Rheacell Gmbh & Co. Kg,
Biontech Se,
Molecular Health,
Biorn Life Science Cluster,
Veraxa Biotech,
Affimed,
Heidelberg Pharma Research Gmbh.
Heidelberg Pharma Ag's categories are Biotechnology Research
